CASE REPORT
Published on 01 Aug 2025
Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: a case report
doi 10.3389/fonc.2025.1642412
- 276 views
903
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: